Silencing of Synuclein-γ inhibits human cervical cancer through the AKT signaling pathway

被引:1
作者
Chunnian Zhang
Liqin Gu
Xiafang Li
Jianzhong Wang
机构
[1] Ganzhou People’s Hospital of Jiangxi Province,Department of Gynaecology
来源
Cellular & Molecular Biology Letters | 2019年 / 24卷
关键词
Knockdown; Cervical cancer; Growth; AKT;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 104 条
[1]  
Forouzanfar MH(2011)Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis Lancet 379 1391-1392
[2]  
Foreman KJ(2014)Improved survival with bevacizumab in advanced cervical cancer N Engl J Med 370 734-743
[3]  
Delossantos AM(2014)Cervix cancer brachytherapy: high dose rate Ritorno Al Numero 18 452-457
[4]  
Lozano R(2012)Values of three different preoperative regimens in comprehensive treatment for young patients with stage Ib2 cervical cancer Asian Pac J Cancer Prev 13 1487-1489
[5]  
Lopez AD(2012)Cervical cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up Ann Oncol 23 vii27-7
[6]  
Murray CJ(2004)Demethylation of the Synuclein gamma gene CpG island in primary gastric cancers and gastric cancer cell lines Clin Cancer Res 10 2447-764
[7]  
Tewari KS(2014)Synuclein-gamma predicts poor clinical outcome in esophageal cancer patients Tumour Biol 35 1-65
[8]  
Sill MW(1997)Identification of a breast cancer-specific gene, BCSG1, by direct differential cDNA sequencing Cancer Res 57 759-2163
[9]  
Penson RT(2004)Overexpression of synuclein-γ in pancreatic adenocarcinoma Cancer 101 58-663
[10]  
Huang H(2015)Synucleins are expressed in the majority of breast and ovarian carcinomas and in preneoplastic lesions of the ovary Cancer 88 2154-5171